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Summary. Small cell carcinoma is a rare neoplasm in 
the esophagus. To evaluate cell proliferation activity and 
its underlying mechanisms in this tumor, we examined 
immunohistochemically 5 cases of small cell carcinoma 
of the esophagus (SCCE) for expressions of tumor 
suppressor proteins, oncoproteins and cell proliferation 
markers including p53, p21WAF1/C1P1, retinoblastoma 
(Rb) protein, bcl-2, Ki-67 and PCNA, and compared the 
results with those of 5 cases of small cell carcinoma of 
the lung (SCCL) and 10 cases of squamous cell 
carcinoma of the esophagus (SQCE). The prevalence 
and labeling index of p53-immunoreactivity tended to 
be higher in SCCE (415; 56.6%) and SCCL (415; 
79.9%) than in SQCE (6110; 48.8%). Expression of 
p21wAFl/C1P1 was observed in 2 of 10 cases of SQCE. 
In contrast, its expression could not be detected in any 
cases of SCCE and SCCL examined. Expression of Rb 
protein was observed in 9 out of 10 cases of SQCE, but 
not in any cases of SCCE and SCCL. SCCE and SCCL 
showed more frequent and intense immunoreactivity for 
bcl-2 than SQCE. In expression of cell proliferation 
markers (Ki-67 and PCNA), no remarkable difference 
was observed among SCCE, SCCL and SQCE. These 
results suggest that SCCE and SCCL could share some 
genetic alternations including mutation of p53, loss of 
Rb gene and overexpression of bcl-2, and these may be 
related to the similar biological potentials between the 
two. Futhermore, SCCE was different from SQCE in 
expression of Rb protein and bcl-2, and these two types 
of esophageal carcinoma could arise through different 
molecular mechanisms. 
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Introduction 
Small cell carcinoma of the esophagus (SCCE) was 
first described by McKeown in 1952 and since then 
more than 200 cases have been reported in the literature 
(Casas et al., 1997). Small cell carcinoma, histologically 
indistinguishable from that of the lung, arises in a wide 
variety of extrapulmonary sites, such as the larynx, 
salivary gland, digestive tract, pancreas, uterus, prostate, 
urinary bladder, thymus, skin, breast and so on, but its 
incidence is very low when compared with that of the 
lung (Galanis et al., 1997). Extrapulmonary small cell 
carcinoma occurs not so infrequently in the esophagus, 
and its incidence is reported to be 0.05% to 9.0% of all 
esophageal tumors (Briggs and Ibrahim, 1983; Mori et 
al., 1989; Sasajima et al., 1990; Huncharek and Muscat, 
1995; Galanis et al., 1997). The highest prevalence of 
SCCE is observed in East Asia (Briggs and Ibrahim, 
1983; Mori et al., 1989). SCCE, like that of lung origin, 
is regarded to have a poor prognosis because of its rapid 
growth rate and early systemic dissemination (Briggs 
and Ibrahim, 1983; Mori et al., 1989; Huncharek and 
Muscat, 1995; Casas et al., 1997). The median survival 
after diagnosis reportedly ranges from 3.3 to 20.7 
months (Briggs and Ibrahim, 1983; Mori et al., 1989; 
Casas et al., 1995; Huncharek and Muscat, 1995). 
Moreover SCCE, as is well known in that of the lung, 
also shows neuroendocrine differentitation (Springall et 
al., 1986; Mori et al., 1989; Sasajima et al., 1990; 
Tennvall et al., 1990; Hoda and Haidju, 1992; Nishimaki 
et al., 1993). Although the histogenesis of SCCE is still 
controversial, Ho et al. (1984) suggested that a totipotent 
primitive cell could serve as the common precursor for 
squamous cell carcinoma, adenocarcinoma and SCCE, 
because coexistence of each histological type is often 
seen. In clinical outcome, microscopic appearance and 
its neuroendocrine differentiation, SCCE has similar 
characteristics to small cell carcinoma of the lung 






